Pliant Therapeutics Inc.
PLRX | NASDAQ
$0.86
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$0.85
-$0.01 (-1.16%)
Pre-market:
Nov 2, 2026, 8:51 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.50 | -3.80 | -6.59 | -6.57 | -4.98 | -19.42 |
PEG Ratio | 0.02 | -0.14 | 1.02 | -0.77 | -0.04 | -0.04 |
PS Ratio | n/a | n/a | 673.04 | 83.86 | 63.91 | 19.32 |
PB Ratio | 0.41 | 2.62 | 2.25 | 2.59 | 2.43 | 2.85 |
P/FCF Ratio | -0.58 | -5 | -9.07 | -8.43 | -6.25 | -20.82 |
P/OCF Ratio | -0.58 | -5.13 | -9.14 | -8.58 | -6.41 | -21.67 |
OCF/S Ratio | n/a | n/a | -7.36K | -977.09 | -996.34 | -89.13 |
Debt / Equity Ratio | 0.16 | 0.20 | 0.02 | 0.05 | 0.04 | n/a |
Quick Ratio | 12 | 10.91 | 17.72 | 14.23 | 12.44 | 25.07 |
Current Ratio | 12 | 10.91 | 17.72 | 14.23 | 12.44 | 25.07 |
Asset Turnover | n/a | n/a | 0 | 0.03 | 0.03 | 0.14 |
Interest Coverage | -58.65 | -75.52 | -145.34 | -160.81 | n/a | -113.78 |
Return on Equity | -82.42% | -69.16% | -34.07% | -39.36% | -48.86% | -14.67% |
Return on Assets | -66.31% | -52.98% | -31.50% | -35.17% | -43.97% | -14.05% |
Return on Invested Capital | -71.36% | -62.69% | -37.97% | -38.64% | -47.29% | -14.67% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 100% | 100% | 100% | 100% |
Net Profit Margin | n/a | n/a | -10.21K% | -1.27K% | -1.28K% | -99.32% |
Pretax Profit Margin | n/a | n/a | -10.21K% | -1.27K% | -1.28K% | -99.32% |
Operating Profit Margin | n/a | n/a | -11.65K% | -1.31K% | -1.29K% | -99.59% |
FCF Margin | n/a | n/a | -7.42K% | -995.26% | -1.02K% | -92.79% |
EBITDA Margin | n/a | n/a | -10.01K% | -1.23K% | -1.26K% | -96.46% |
Add to Watchlist
Select watchlists to add or remove PLRX